BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38650013)

  • 1. Squamous cell carcinoma initially occurring on the tongue dorsum: a case series report with molecular analysis.
    Ono S; Hirose K; Sukegawa S; Obata K; Masui M; Hasegawa K; Fujimura A; Shimada K; Nakamura S; Teramoto A; Hori Y; Morii E; Motooka D; Igawa T; Tanaka T; Nagatsuka H; Toyosawa S; Yamamoto H
    Diagn Pathol; 2024 Apr; 19(1):63. PubMed ID: 38650013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TP53 and CDKN2a mutations in never-smoker oral tongue squamous cell carcinoma.
    Heaton CM; Durr ML; Tetsu O; van Zante A; Wang SJ
    Laryngoscope; 2014 Jul; 124(7):E267-73. PubMed ID: 24431303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral squamous cell carcinoma of the tongue dorsum with multiple cancer-associated mutations in the TP53 gene.
    Yamasaki S; Tani R; Sakurai S; Toratani S; Okamoto T
    Oral Oncol; 2020 Oct; 109():104774. PubMed ID: 32451170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular characterisation in tongue squamous cell carcinoma reveals key variants potentially linked to clinical outcomes.
    Alsofyani AA; Dallol A; Farraj SA; Alsiary RA; Samkari A; Alhaj-Hussain BT; Khan JA; Al-Maghrabi J; Al-Khayyat SS; Alkhatabi H; Elaimi A; Buhmeida A; Johargy AK; Abuzenadah AM; Azhar EI; Al-Qahtani MH
    Cancer Biomark; 2020; 28(2):213-220. PubMed ID: 32250288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clear Cell Squamous Cell Carcinoma of the Maxillary Gingiva Associated with PIK3CA and HRAS Mutations: Report of a Case and Literature Review.
    Hirose K; Shibahara T; Teramoto A; Usami Y; Ono S; Iwamoto Y; Murakami S; Oya K; Uzawa N; Motooka D; Hori Y; Morii E; Toyosawa S
    Head Neck Pathol; 2023 Dec; 17(4):1026-1033. PubMed ID: 37735286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted sequencing reveals TP53 as a potential diagnostic biomarker in the post-treatment surveillance of head and neck cancer.
    van Ginkel JH; de Leng WW; de Bree R; van Es RJ; Willems SM
    Oncotarget; 2016 Sep; 7(38):61575-61586. PubMed ID: 27528217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic alterations in head and neck squamous cell carcinoma determined by cancer gene-targeted sequencing.
    Chung CH; Guthrie VB; Masica DL; Tokheim C; Kang H; Richmon J; Agrawal N; Fakhry C; Quon H; Subramaniam RM; Zuo Z; Seiwert T; Chalmers ZR; Frampton GM; Ali SM; Yelensky R; Stephens PJ; Miller VA; Karchin R; Bishop JA
    Ann Oncol; 2015 Jun; 26(6):1216-1223. PubMed ID: 25712460
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Akagi Y; Tachibana T; Orita Y; Gion Y; Marunaka H; Makino T; Miki K; Akisada N; Yoshino T; Nishizaki K; Sato Y
    Acta Otolaryngol; 2019 Jul; 139(7):647-651. PubMed ID: 31066593
    [No Abstract]   [Full Text] [Related]  

  • 9. The Driver Mutational Landscape of Ovarian Squamous Cell Carcinomas Arising in Mature Cystic Teratoma.
    Cooke SL; Ennis D; Evers L; Dowson S; Chan MY; Paul J; Hirschowitz L; Glasspool RM; Singh N; Bell S; Day E; Kochman A; Wilkinson N; Beer P; Martin S; Millan D; Biankin AV; McNeish IA;
    Clin Cancer Res; 2017 Dec; 23(24):7633-7640. PubMed ID: 28954785
    [No Abstract]   [Full Text] [Related]  

  • 10. HPV-negative Squamous Cell Carcinomas of the Cervix With Special Focus on Intraepithelial Precursor Lesions.
    Regauer S; Reich O; Kashofer K
    Am J Surg Pathol; 2022 Feb; 46(2):147-158. PubMed ID: 34387215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic Alterations in Human Papillomavirus-Positive and -Negative Conjunctival Squamous Cell Carcinomas.
    Ramberg I; Vieira FG; Toft PB; von Buchwald C; Funding M; Nielsen FC; Heegaard S
    Invest Ophthalmol Vis Sci; 2021 Nov; 62(14):11. PubMed ID: 34779821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Next-Generation Sequencing of a Cohort of Pulmonary Large Cell Carcinomas Reclassified by World Health Organization 2015 Criteria.
    Driver BR; Portier BP; Mody DR; Deavers M; Bernicker EH; Kim MP; Teh BS; Santacruz JF; Kopas L; Munden RF; Cagle PT
    Arch Pathol Lab Med; 2016 Apr; 140(4):312-7. PubMed ID: 26430808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted next-generation sequencing of TP53 in oral tongue carcinoma from non-smokers.
    Faden DL; Arron ST; Heaton CM; DeRisi J; South AP; Wang SJ
    J Otolaryngol Head Neck Surg; 2016 Sep; 45(1):47. PubMed ID: 27640185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive genomic profiling of head and neck squamous cell carcinoma reveals FGFR1 amplifications and tumour genomic alterations burden as prognostic biomarkers of survival.
    Dubot C; Bernard V; Sablin MP; Vacher S; Chemlali W; Schnitzler A; Pierron G; Ait Rais K; Bessoltane N; Jeannot E; Klijanienko J; Mariani O; Jouffroy T; Calugaru V; Hoffmann C; Lesnik M; Badois N; Berger F; Le Tourneau C; Kamal M; Bieche I
    Eur J Cancer; 2018 Mar; 91():47-55. PubMed ID: 29331751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disruptive TP53 mutation is associated with aggressive disease characteristics in an orthotopic murine model of oral tongue cancer.
    Sano D; Xie TX; Ow TJ; Zhao M; Pickering CR; Zhou G; Sandulache VC; Wheeler DA; Gibbs RA; Caulin C; Myers JN
    Clin Cancer Res; 2011 Nov; 17(21):6658-70. PubMed ID: 21903770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigating the Feasibility of Targeted Next-Generation Sequencing to Guide the Treatment of Head and Neck Squamous Cell Carcinoma.
    Lim SM; Cho SH; Hwang IG; Choi JW; Chang H; Ahn MJ; Park KU; Kim JW; Ko YH; Ahn HK; Cho BC; Nam BH; Chun SH; Hong JH; Kwon JH; Choi JG; Kang EJ; Yun T; Lee KW; Kim JH; Kim JS; Lee HW; Kim MK; Jung D; Kim JE; Keam B; Yun HJ; Kim S; Kim HR
    Cancer Res Treat; 2019 Jan; 51(1):300-312. PubMed ID: 29747488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carcinoma of the dorsum of the tongue.
    Goldenberg D; Ardekian L; Rachmiel A; Peled M; Joachims HZ; Laufer D
    Head Neck; 2000 Mar; 22(2):190-4. PubMed ID: 10679909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mutational landscape of early- and typical-onset oral tongue squamous cell carcinoma.
    Campbell BR; Chen Z; Faden DL; Agrawal N; Li RJ; Hanna GJ; Iyer NG; Boot A; Rozen SG; Vettore AL; Panda B; Krishnan NM; Pickering CR; Myers JN; Guo X; Lang Kuhs KA
    Cancer; 2021 Feb; 127(4):544-553. PubMed ID: 33146897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical, genomic, and metagenomic characterization of oral tongue squamous cell carcinoma in patients who do not smoke.
    Li R; Faden DL; Fakhry C; Langelier C; Jiao Y; Wang Y; Wilkerson MD; Pedamallu CS; Old M; Lang J; Loyo M; Ahn SM; Tan M; Gooi Z; Chan J; Richmon J; Wood LD; Hruban RH; Bishop J; Westra WH; Chung CH; Califano J; Gourin CG; Bettegowda C; Meyerson M; Papadopoulos N; Kinzler KW; Vogelstein B; DeRisi JL; Koch WM; Agrawal N
    Head Neck; 2015 Nov; 37(11):1642-9. PubMed ID: 24954188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent genetic alterations and biomarker expression in primary and metastatic squamous cell carcinomas of the vulva.
    Xing D; Liu Y; Park HJ; Baek I; Tran H; Cheang G; Novo J; Dillon J; Matoso A; Farmer E; Cheng MA; Tsai YC; Lombardo K; Conner MG; Vang R; Hung CF; Wu TC; Song W
    Hum Pathol; 2019 Oct; 92():67-80. PubMed ID: 31437519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.